The binding spectrum of narcotic analgesic drugs with different agonist and antagonist properties

[1]  C. Chavkin,et al.  Dynorphin is a specific endogenous ligand of the κ opioid receptor Science, 215 (1982) 413–415 , 1982, Pain.

[2]  C. Chavkin,et al.  Dynorphin is a specific endogenous ligand of the kappa opioid receptor. , 1982, Science.

[3]  A. Herz,et al.  A subclassification of κ-sites in human brain by use of dynorphin 1–17 , 1981, Neuropeptides.

[4]  T. Su.  Psychotomimetic opioid binding: specific binding of [3H]SKF-10047 to etorphine-inaccessible sites in guinea-pig brain. , 1981, European journal of pharmacology.

[5]  G. Pasternak,et al.  Classification of multiple morphine and enkephalin binding sites in the central nervous system. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[6]  R. Schulz,et al.  The preference of putative pro-enkephalins for different types of opiate receptors. , 1981, Life sciences.

[7]  R. Zukin,et al.  Demonstration of [3H]cyclazocine binding to multiple opiate receptor sites. , 1981, Molecular pharmacology.

[8]  M. Herkenham,et al.  Phencyclidine (angel dust)/sigma "opiate" receptor: visualization by tritium-sensitive film. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[9]  G. Pasternak,et al.  Opiates and enkephalins: a common binding site mediates their analgesic actions in rats. , 1981, Life sciences.

[10]  H. Kosterlitz,et al.  CHARACTERIZATION OF THE k‐SUBTYPE OF THE OPIATE RECEPTOR IN THE GUINEA‐PIG BRAIN , 1981 .

[11]  H. Kosterlitz,et al.  SOME 14β-SUBSTITUTED ANALOGS OF N-(CYCLOPROPYLMETHYL)NORMORPHINE , 1981 .

[12]  M. Adler.  The in vivo differentiation of opiate receptors: introduction. , 1981, Life sciences.

[13]  A. Cowan.  Simple in vivo tests that differentiate prototype agonists at opiate receptors. , 1981, Life sciences.

[14]  J. Woods,et al.  Discriminative stimulus effects of narcotics: evidence for multiple receptor-mediated actions. , 1981, Life sciences.

[15]  H. Kosterlitz,et al.  Some 14 beta-substituted analogues of N-(cyclopropylmethyl)normorphine. , 1981, Journal of medicinal chemistry.

[16]  H. Kosterlitz,et al.  UNEXPECTED ANTAGONISM IN THE RAT VAS DEFERENS BY BENZOMORPHANS WHICH ARE AGONISTS IN OTHER PHARMACOLOGICAL TESTS , 1981, British journal of pharmacology.

[17]  A. Tavani,et al.  Activity profiles of opiates at the μ-, δ- and kappa-binding sites , 1981 .

[18]  H. Kosterlitz,et al.  COMPARISON OF THE BINDING CHARACTERISTICS OF TRITIATED OPIATES AND OPIOID PEPTIDES , 1980, British journal of pharmacology.

[19]  H. Kosterlitz,et al.  Characterization of opioid receptors in nervous tissue , 1980, Proceedings of the Royal Society of London. Series B. Biological Sciences.

[20]  H. Kosterlitz,et al.  EFFECTS OF CHANGES IN THE STRUCTURE OF ENKEPHALINS AND OF NARCOTIC ANALGESIC DRUGS ON THEIR INTERACTIONS WITH μ‐ AND δ‐RECEPTORS , 1980 .

[21]  R. Schulz,et al.  OPIOID AGONISTS AND ANTAGONISTS: ACTION ON MULTIPLE OPIATE RECEPTORS , 1980 .

[22]  J. Thompson,et al.  Tolerance to and physical dependence on N-allylnormetazocine (NANM) in chronic spinal dogs. , 1980, Substance and alcohol actions/misuse.

[23]  D. Regoli,et al.  RAT VAS DEFERENS: A SPECIFIC BIOASSAY FOR ENDOGENOUS OPIOID PEPTIDES , 1978, British journal of pharmacology.

[24]  John Hughes,et al.  Endogenous opioid peptides: multiple agonists and receptors , 1977, Nature.

[25]  G. Henderson,et al.  In vitro pharmacology of the opioid peptides, enkephalins and endorphins. , 1977, European journal of pharmacology.

[26]  W. Martin,et al.  The effects of morphine and nalorphine-like drugs in the nondependent, morphine-dependent and cyclazocine-dependent chronic spinal dog. , 1976, The Journal of pharmacology and experimental therapeutics.

[27]  J. Thompson,et al.  The effects of morphine- and nalorphine- like drugs in the nondependent and morphine-dependent chronic spinal dog. , 1976, The Journal of pharmacology and experimental therapeutics.

[28]  L. Terenius,et al.  ASSESSMENT IN THE GUINEA‐PIG ILEUM AND MOUSE VAS DEFERENS OF BENZOMORPHANS WHICH HAVE STRONG ANTINOCICEPTIVE ACTIVITY BUT DO NOT SUBSTITUTE FOR MORPHINE IN THE DEPENDENT MONKEY , 1975, British journal of pharmacology.

[29]  D. Lewis.  Narcotic Antagonists (Advances in Biochemical Psychopharmacology, Vol. 8) , 1975 .

[30]  H. Kosterlitz,et al.  Stereospecific increase by narcotic antagonists of evoked acetylcholine output in guinea-pig ileum. , 1975, Life sciences.

[31]  F. Leslie,et al.  Rates of onset and offset of action of narcotic analgesics in isolated preparations. , 1975, European journal of pharmacology.

[32]  F. Leslie,et al.  EFFECT OF MORPHINE ON ADRENERGIC TRANSMISSION IN THE MOUSE VAS DEFERENS. ASSESSMENT OF AGONIST AND ANTAGONIST POTENCIES OF NARCOTIC ANALGESICS , 1975, British journal of pharmacology.

[33]  H. Kosterlitz,et al.  In vitro models in the study of structure-activity relationships of narcotic analgesics. , 1975, Annual review of pharmacology.

[34]  Y. Cheng,et al.  Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. , 1973, Biochemical pharmacology.

[35]  V. Berthoud,et al.  Assessment of the agonist and antagonist properties of narcotic analgesic drugs by their actions on the morphine receptor in the guinea pig ileum. , 1973, Advances in biochemical psychopharmacology.

[36]  A. Watt,et al.  The effects of adrenaline, noradrenaline and isoprenaline on inhibitory α‐ and β‐adrenoceptors in the longitudinal muscle of the guinea‐pig ileum , 1970, British journal of pharmacology.

[37]  A. Watt,et al.  Kinetic parameters of narcotic agonists and antagonists, with particular reference to N-allylnoroxymorphone (naloxone). , 1968, British journal of pharmacology and chemotherapy.

[38]  W. Martin.  Opioid antagonists. , 1967, Pharmacological reviews.

[39]  H. Schild,et al.  SOME QUANTITATIVE USES OF DRUG ANTAGONISTS , 1997, British journal of pharmacology and chemotherapy.